Molecular characterization of a TEM-21 beta-lactamase in a clinical isolate of Morganella morganii

Antimicrob Agents Chemother. 1998 Aug;42(8):2125-7. doi: 10.1128/AAC.42.8.2125.

Abstract

A clinical isolate of Morganella morganii, with reduced susceptibility to expanded-spectrum cephalosporins and aztreonam, was found to produce an extended-spectrum beta-lactamase with a pI of 6.4. The nucleotide sequence of the encoding gene was that of the gene encoding TEM-21. This is the first molecular characterization of an extended-spectrum beta-lactamase in M. morganii.

MeSH terms

  • Base Sequence
  • Humans
  • Microbial Sensitivity Tests
  • Molecular Sequence Data
  • Proteus / drug effects
  • Proteus / enzymology*
  • beta-Lactamases / genetics*

Substances

  • beta-Lactamases